AI assistant
BB Biotech AG Major Shareholding Notification 2025
833_rns_2025-06-23_cb5ec62b-4ca6-4a34-af8e-aa1bc1a4d85f.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
News Details
Voting rights Announcements | 23 June 2025 07:00
Disclosure of Shareholdings
BB BIOTECH AG
Disclosure of Shareholdings
23.06.2025 / 07:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Disclosure of Shareholdings
Submited, 18/06/2026
Notification ID: 77b1d1cb-63b3-4b8f-b0f1-bb767e0006e7
Disclosure notification concerning a single investor
Name of listed company
BB Biotech AG
PART 1: PERSON SUBJECT TO REPORTING OBLIGATION
Last name, first name, place of residence or company name and head office of the beneficial owner (art. 120 para. 1 FMIA) and/ or of the person who has the discretionary power to exercise the voting rights (art. 120 para. 3 FMIA):
Company: Saba Capital Management, L.P
City: New York
Country: United States of America (the)
PART 2: IN CASE OF INDIRECT PARTICIPATION
Last name, first name, place of residence or company name and head office of the person/s directly involved
PART 3: DATE AND REASON FOR THE REPORTING OBLIGATION
Date of the act that creates the obligation to notify: 17.06.2025
Facts and circumstances triggering the obligation to notify (art. 22 para. 1 b FMIO-FINMA):
X Acquisition
Sale
Creation of a group
Change in group composition Termination of a group
Discretionary exercise of voting rights
Securities lending and comparable transactions
Exercise, non-exercise or expiration of derivative holdings
Granting (writing) of derivative holdings
Capital increase
Capital reduction
Ipso jure transfer or transfer due to a decision by a court or public authority
Change in the information subject to the obligation to notify
Other
Total of voting rights below 3%
If the participation falls below the threshold of 3% (purchase positions and sale positions), no indication in Part 4 or Part 5 is required.
Total of voting rights <3%
PART 4: PURCHASE POSITIONS PURSUANT TO ART. 14 PARA. 1 A FMIO- FINMA
Total of all purchase positions:
Total of all equity securities or equity related securities (item 1), number of voting rights that can be exercised at one’s own discretion (item 3) and derivative holdings (item 4)
| Number of voting rights | Percentage |
| S1 = [1.1] + [3.1] + [4.1] | S2 = [1.2] + [3.2] + [4.2] |
| 1,697,636 | 3.064% |
Basis of calculation (art. 14 para. 2 FMIO-FINMA): total number of voting rights pursuant to the entry in the commercial register (see Central Business Names Index ) or Publication according to art. 115 para. 3 FMIO:
55,400,000
- Equity securities or equity related securities
| Shares | Number | Voting rights 1 | |
| Number | Percentage2 | ||
| Registered share | 503,638 | 503,638 | 0.909% |
| Total | [1.1] 503,638 |
[1.2] 0.909% |
- Whether exercisable or not
-
Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)
-
Securities lending and comparable transactions in equity securities
Of the equity securities mentioned in item 1 above , the following part is held due to securities lending and comparable transactions (art. 17 FMIO-FINMA):
| Shares | Number | Proportion of voting rights | Nature of the legal transaction |
Agreed date of return transfer or, if there is a right to choose, whether this applies to the contracting party subject to the obligation to notify or to the counterparty |
- Voting rights that can be exercised at one’s own discretion
The following voting rights were delegated by a third party and can be exercised at one’s own discretion.
Voting rights
Is the person who has full discretionary powers to exercise voting rights directly or indirectly controlled?
Yes No
- Derivative holdings
Conversion and share purchase rights (such as call-options according to art. 15 para. 2 a FMIO-FINMA), granted (written) share sale rights and other derivative holdings:
| Type of rights | Number of rights | Number of voting rights conferred | Security ID number (ISIN) if available or basic terms | |
| Number | Percentage2 | Identity of issuer, subscription ratio, exercise price, exercise period, exercise type |
||
| CFD | 1,193,998 | 1,193,998 | 2.155% | CH0038389992 |
| [4.1] | [4.2] | |||
| Total | 1,193,998 | 2.155% |
2 Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)
- Securities lending and comparable transactions in derivative holdings
Of the derivative holdings mentioned in item 4 above , the following part is held due to securities lending and comparable transactions (art. 17 FMIO-FINMA):
| Nature of the legal transaction | Number of rights | Number of reported voting rights |
Proportion of voting rights | Agreed date of return transfer or, if there is a right to choose, whether this applies to the contracting party subject to the obligation to notify or to the counterparty |
PART 5: SALE POSITIONS PURSUANT TO ART. 14 PARA. 1 B FMIO- FINMA
Total of all sale positions:
Basis of calculation (art. 14 para. 2 FMIO-FINMA): total number of voting rights pursuant to the entry in the commercial register (see Central Business Names Index ) or Publication according to art. 115 para. 3 FMIO:
55,400,000
Derivative holdings
Share sale rights (such as put-options according to art. 15 para. 2 a FMIO-FINMA), granted (written) conversion and share purchase rights and other derivative holdings:
| Type of rights | Number of rights | Number of voting rights conferred | Security ID number (ISIN) if available or basic terms | |
| Number | Percentage2 | Identity of issuer, subscription ratio, exercise price, exercise period, exercise type |
Total
2 Calculated on the basis of the total number of voting rights pursuant to the entry in the commercial register (art. 14 para. 2 FMIO-FINMA)
23.06.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | BB BIOTECH AG |
| Schwertstrasse 6 | |
| 8200 Schaffhausen | |
| Switzerland | |
| Internet: | www.bbbiotech.ch |
| End of News | EQS News Service |
2158408 23.06.2025 CET/CEST